• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Kyverna Therapeutics, Inc. - Common Stock (NQ: KYTX )

    4.000 +0.130 (+3.36%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,404,265
    Open 3.820
    Bid (Size) 3.830 (1)
    Ask (Size) 4.320 (10)
    Prev. Close 3.870
    Today's Range 3.760 - 4.090
    52wk Range 3.625 - 35.06
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CLASS ACTION NOTICE FOR KYTX: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Losses to Contact the Firm
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Fraud Initial Public Offering Lawsuit
    Exposures Financial Legal Securities Market
    CLASS ACTION NOTICE FOR KYTX: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Losses to Contact the Firm
    RADNOR, PA - (NewMediaWire) - December 20, 2024 - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against... 
    Via TheNewswire.com
    Topics Fraud Initial Public Offering Lawsuit
    Exposures Financial Legal Securities Market

    Performance

    YTD
    -86.67%
    -86.67%
    1 Month
    +0.25%
    +0.25%
    3 Month
    -31.57%
    -31.57%
    6 Month
    -49.30%
    -49.30%
    1 Year
    -86.67%
    -86.67%

    More News

    Read More
    KYTX Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Kyverna Therapeutics, Inc. - Contact Kessler Topaz Meltzer & Check, LLP
    From Kessler Topaz Meltzer & Check LLP
    Via GlobeNewswire
    SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kyverna Therapeutics, Inc. (KYTX)
    From Glancy Prongay & Murray LLP
    Via Business Wire
    KYTX Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Kyverna Therapeutics, Inc.
    From Kessler Topaz Meltzer & Check, LLP
    Via Business Wire
    Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kyverna Therapeutics, Inc. (KYTX)
    From Law Offices of Howard G. Smith
    Via Business Wire
    KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Kyverna Therapeutics, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    KYVERNA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Kyverna Therapeutics, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Kyverna Therapeutics, Inc. (KYTX) Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
    Via ACCESSWIRE
    Levi & Korsinsky Notifies Kyverna Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - KYTX
    Via ACCESSWIRE
    Class Action Filed Against Kyverna Therapeutics, Inc. (KYTX) Seeking Recovery for Investors – Contact Levi & Korsinsky
    Via ACCESSWIRE
    February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX
    Via ACCESSWIRE
    The Schall Law Firm Urges Stockholder Participation In A Securities Fraud Case Against Kyverna Therapeutics Inc
    Via ACCESSWIRE
    Investors in Kyverna Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your Rights - KYTX
    Via ACCESSWIRE
    The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Kyverna Therapeutics, Inc. (KYTX) Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    Levi & Korsinsky Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025 - KYTX
    Via ACCESSWIRE
    Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 7, 2025 in Kyverna Therapeutics, Inc. Lawsuit - KYTX
    Via ACCESSWIRE
    KYTX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    From Robbins Geller Rudman & Dowd LLP
    Via Business Wire
    Kyverna Therapeutics, Inc. Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Contact The Schall Law Firm
    Via ACCESSWIRE
    KYTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 7, 2025 in Kyverna Therapeutics, Inc. Lawsuit - KYTX
    Via ACCESSWIRE
    Levi & Korsinsky Notifies Shareholders of Kyverna Therapeutics, Inc.(KYTX) of a Class Action Lawsuit and an Upcoming Deadline
    Via ACCESSWIRE
    February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX
    Via ACCESSWIRE
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.